These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1520340)

  • 1. Complex role of protein kinase C in mediating the supramaximal inhibition of pancreatic secretion observed with cholecystokinin.
    Gaisano HY; Miller LJ
    Biochem Biophys Res Commun; 1992 Aug; 187(1):498-506. PubMed ID: 1520340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of Ca2+ oscillations induced by cholecystokinin (CCK) and its analog OPE in rat pancreatic acinar cells by low-level protein kinase C activation without transition of the CCK receptor from a high- to low-affinity state.
    Gaisano HY; Miller LJ; Foskett JK
    Pflugers Arch; 1994 Jul; 427(5-6):455-62. PubMed ID: 7971144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cholecystokinin (CCK) and other secretagogues on isoforms of protein kinase C (PKC) in pancreatic acini.
    Pollo DA; Baldassare JJ; Honda T; Henderson PA; Talkad VD; Gardner JD
    Biochim Biophys Acta; 1994 Oct; 1224(1):127-38. PubMed ID: 7524684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low concentrations of protein kinase C-activating agonists suppress cholecystokinin-OPE-evoked Ca2+ mobilization in rat pancreatic acini.
    Gaisano HY; Miller LJ
    Pancreas; 1994 Jul; 9(4):450-3. PubMed ID: 7937693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for cholecystokinin-stimulated protein tyrosine phosphorylation in regulated secretion by the pancreatic acinar cell.
    Lutz MP; Sutor SL; Abraham RT; Miller LJ
    J Biol Chem; 1993 May; 268(15):11119-24. PubMed ID: 7684371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor-evoked Ca2+ mobilization in pancreatic acinar cells: evidence for a regulatory role of protein kinase C by a mechanism involving the transition of high-affinity receptors to a low-affinity state.
    Willems PH; Van Hoof HJ; Van Mackelenbergh MG; Hoenderop JG; Van Emst-De Vries SE; De Pont JJ
    Pflugers Arch; 1993 Jul; 424(2):171-82. PubMed ID: 7692387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbachol regulates cholecystokinin receptor on pancreatic acinar cells.
    Honda T; Adachi H; Noguchi M; Sato S; Onishi S; Aoki E; Torizuka K
    Am J Physiol; 1987 Jan; 252(1 Pt 1):G77-83. PubMed ID: 3101510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of RhoA and its interaction with protein kinase C and Src in CCK-stimulated pancreatic acini.
    Nozu F; Tsunoda Y; Ibitayo AI; Bitar KN; Owyang C
    Am J Physiol; 1999 Apr; 276(4):G915-23. PubMed ID: 10198335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phorbol ester attenuates cholecystokinin-stimulated amylase release in pancreatic acini of rats.
    Lee PC; Leung YK; Srimaruta N; Cumella J; Rossi T
    Biochim Biophys Acta; 1987 Oct; 931(1):101-9. PubMed ID: 2443187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-affinity CCK-1 receptors inhibit bombesin-stimulated secretion in rat pancreatic acini--implication of the actin cytoskeleton.
    Kiehne K; Herzig KH; Otte JM; Fölsch UR
    Regul Pept; 2002 May; 105(2):131-7. PubMed ID: 11891013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Jun kinases are rapidly activated by cholecystokinin in rat pancreas both in vitro and in vivo.
    Dabrowski A; Grady T; Logsdon CD; Williams JA
    J Biol Chem; 1996 Mar; 271(10):5686-90. PubMed ID: 8621433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbachol acts through protein kinase C to modulate cholecystokinin receptors on pancreatic acini.
    Louie DS; Chung OY
    Am J Physiol; 1991 Dec; 261(6 Pt 1):G981-6. PubMed ID: 1722647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of MAP kinase kinase (MEK) and Ras by cholecystokinin in rat pancreatic acini.
    Duan RD; Zheng CF; Guan KL; Williams JA
    Am J Physiol; 1995 Jun; 268(6 Pt 1):G1060-5. PubMed ID: 7611406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonist-regulated phosphorylation of the pancreatic cholecystokinin receptor.
    Klueppelberg UG; Gates LK; Gorelick FS; Miller LJ
    J Biol Chem; 1991 Feb; 266(4):2403-8. PubMed ID: 1989991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple kinases phosphorylate the pancreatic cholecystokinin receptor in an agonist-dependent manner.
    Gates LK; Ulrich CD; Miller LJ
    Am J Physiol; 1993 May; 264(5 Pt 1):G840-7. PubMed ID: 8498511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supramaximal CCK and CCh concentrations abolish VIP potentiation by inhibiting adenylyl cyclase activity.
    Akiyama T; Hirohata Y; Okabayashi Y; Imoto I; Otsuki M
    Am J Physiol; 1998 Nov; 275(5):G1202-8. PubMed ID: 9815052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCKA receptor activation stimulates p130(Cas) tyrosine phosphorylation, translocation, and association with Crk in rat pancreatic acinar cells.
    Ferris HA; Tapia JA; García LJ; Jensen RT
    Biochemistry; 1999 Feb; 38(5):1497-508. PubMed ID: 9931015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholecystokinin JMV-180 and caerulein effects on the pancreatic acinar cell cytoskeleton.
    O'Konski MS; Pandol SJ
    Pancreas; 1993 Sep; 8(5):638-46. PubMed ID: 7508112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCK causes PKD1 activation in pancreatic acini by signaling through PKC-delta and PKC-independent pathways.
    Berna MJ; Hoffmann KM; Tapia JA; Thill M; Pace A; Mantey SA; Jensen RT
    Biochim Biophys Acta; 2007 Apr; 1773(4):483-501. PubMed ID: 17306383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced cholecystokinin receptor phosphorylation and restored signalling in protein kinase C down-regulated rat pancreatic acinar cells.
    Smeets RL; Rao RV; van Emst-de Vries SE; De Pont JJ; Miller LJ; Willems PH
    Pflugers Arch; 1998 Feb; 435(3):422-8. PubMed ID: 9426300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.